Neurogene, Inc. (NGNE)
20.92
-0.34
(-1.60%)
USD |
NASDAQ |
Dec 12, 16:00
20.95
+0.03
(+0.14%)
After-Hours: 20:00
Neurogene Shareholders Equity (Quarterly): 265.54M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CorMedix, Inc. | 374.13M |
| Verastem, Inc. | -15.53M |
| Anavex Life Sciences Corp. | 94.87M |
| Coherus Oncology, Inc. | 87.77M |
| Ocugen, Inc. | 3.533M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 287.83M |
| Total Liabilities (Quarterly) | 22.29M |
| Debt to Equity Ratio | 0.0384 |
| Current Ratio | 18.37 |
| Net Debt Paydown Yield | 0.28% |